Neurocrine Biosciences (NBIX) Inventory Average (2017 - 2021)
Historic Inventory Average for Neurocrine Biosciences (NBIX) over the last 5 years, with Q3 2021 value amounting to $26.9 million.
- Neurocrine Biosciences' Inventory Average rose 2629.11% to $26.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $26.9 million, marking a year-over-year increase of 2629.11%. This contributed to the annual value of $22.6 million for FY2020, which is 6084.36% up from last year.
- According to the latest figures from Q3 2021, Neurocrine Biosciences' Inventory Average is $26.9 million, which was up 2629.11% from $29.2 million recorded in Q2 2021.
- In the past 5 years, Neurocrine Biosciences' Inventory Average registered a high of $29.2 million during Q2 2021, and its lowest value of $185000.0 during Q3 2017.
- Its 5-year average for Inventory Average is $16.5 million, with a median of $16.6 million in 2019.
- As far as peak fluctuations go, Neurocrine Biosciences' Inventory Average skyrocketed by 123633.49% in 2018, and later skyrocketed by 2629.11% in 2021.
- Over the past 5 years, Neurocrine Biosciences' Inventory Average (Quarter) stood at $633000.0 in 2017, then skyrocketed by 1236.33% to $8.5 million in 2018, then soared by 66.08% to $14.0 million in 2019, then skyrocketed by 72.97% to $24.3 million in 2020, then rose by 10.7% to $26.9 million in 2021.
- Its last three reported values are $26.9 million in Q3 2021, $29.2 million for Q2 2021, and $29.0 million during Q1 2021.